Next report date
Report period
Q1 2024
EPS estimate
−0.24USD
Revenue estimate
100.00 KUSD
−28.45 MUSD
424.00 KUSD
12.03 M
Om VYNE Therapeutics Inc.
Sektor
Bransch
VD
David Domzalski
Webbplats
Huvudkvarter
Bridgewater
Employees (FY)
10
Grundat
2011
FIGI
BBG00H5W8GM8
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
